{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:51:00Z","timestamp":1791895860896,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009650.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000}}],"reference-count":97,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009650.pub6","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:26:37Z","timestamp":1787862397000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3220-7159","authenticated-orcid":false,"given":"David KH","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Sciences; University of Leicester; Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-0151","authenticated-orcid":false,"given":"Nikki","family":"Jahnke","sequence":"additional","affiliation":[{"name":"Academic Unit of Lifespan and Population Health, Medicine & Health Sciences; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-5364","authenticated-orcid":false,"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[{"name":"Academic Unit of Lifespan and Population Health, Medicine & Health Sciences; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-1598","authenticated-orcid":false,"given":"Marianne S","family":"Muhlebach","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pulmonary Medicine; University of North Carolina; Chapel Hill North Carolina USA"},{"name":"Marsico Lung Institute; University of North Carolina; Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Biomedical Sciences; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Supported by the Cochrane Cystic Fibrosis Review Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD009650.pub6-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcf.2022.06.007","article-title":"Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis","volume":"22","author":"Perrem","year":"2023","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1513\/AnnalsATS.201705-376OC","article-title":"Early respiratory bacterial detection and antistaphylococcal antibiotic prophylaxis in young children with cystic fibrosis","volume":"15","author":"Hurley","year":"2018","journal-title":"Annals of the American Thoracic Society"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/1099-0496(200101)31:1&lt;13::aid-ppul1001&gt;3.0.co;2-n","article-title":"Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis","volume":"31","author":"Ratjen","year":"2001","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0006|cit6","unstructured":"Registry report highlights 2024 Available at https:\/\/www.cysticfibrosis.org.uk\/about-us\/uk-cf-registry\/reporting-and-resources\/2024-registry-report-highlights"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"10408","key":"10.1002\/14651858.CD009650.pub6-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cmi.2024.01.004","article-title":"Infection prevention - how can we prevent transmission of community-onset methicillin-resistant Staphylococcus aureus?","volume":"31","author":"Kao","year":"2025","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/antibiotics11010086","article-title":"Current status of staphylococcal cassette chromosome mec (SCCmec)","volume":"11","author":"Uehara","year":"2022","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcf.2011.02.004","article-title":"Treatment intensity and characteristics of MRSA infection in CF","volume":"10","author":"Muhlebach","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0012|cit12","unstructured":"European Centre for Disease Prevention and Control Surveillance Atlas of Infectious Diseases ecdc.europa.eu\/en\/healthtopics\/antimicrobial-resistance-and-consumption\/antimicrobial_resistance\/database\/Pages\/map_reports.aspx"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0013|cit13","unstructured":"Centers for Disease Control and Prevention Methicillin-resistant Staphylococcus aureus (MRSA) www.cdc.gov\/mrsa\/healthcare\/index.html"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0014|cit14","unstructured":"UK CF Registry Annual Data Report 2024 Available at https:\/\/www.cysticfibrosis.org.uk\/about-us\/uk-cf-registry\/reporting-and-resources"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0015|cit15","unstructured":"UK CF Registry Annual Data Report 2009 Available at https:\/\/www.cysticfibrosis.org.uk\/about-us\/uk-cf-registry\/reporting-and-resources"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0016|cit16","unstructured":"UK Cystic Fibrosis Registry 2020 Annual Data Report Available at https:\/\/www.cysticfibrosis.org.uk\/about-us\/uk-cf-registry\/reporting-and-resources"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0017|cit17","unstructured":"Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry Annual Data report 2020 Availalble at https:\/\/www.cff.org\/medical-professionals\/patient-registry"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0018|cit18","unstructured":"Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry Annual Data report 2024 Availalble at https:\/\/www.cff.org\/medical-professionals\/patient-registry"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcf.2023.10.010","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on mucus and mucociliary clearance in cystic fibrosis","volume":"23","author":"Donaldson","year":"2024","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD009650.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ppul.20604","article-title":"Presence of methicillin-resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function","volume":"42","author":"Ren","year":"2007","journal-title":"Pediatric Pulmonology"},{"issue":"8","key":"10.1002\/14651858.CD009650.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent Methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD009650.pub6-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/ppul.20914","article-title":"The impact of incident methicillin-resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis","volume":"43","author":"Sawicki","year":"2008","journal-title":"Pediatric Pulmonology"},{"issue":"23","key":"10.1002\/14651858.CD009650.pub6-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2","article-title":"Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the US and Canada","volume":"28","author":"Morgan","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcf.2011.08.006","article-title":"Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients","volume":"11","author":"Vanderhelst","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001912.pub4","article-title":"Prophylactic anti-staphylococcal antibiotics for cystic fibrosis","author":"Smyth","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009650.pub6-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.10231","article-title":"Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol","volume":"36","author":"Sol\u00eds","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD009650.pub6-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jama.2010.1115","article-title":"Health care-associated invasive MRSA infections, 2005-2008","volume":"304","author":"Kallen","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0924-8579(09)70551-5","article-title":"MRSA burden and interventions","volume":"34 Suppl 3","author":"Liebowitz","year":"2009","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/jac\/dkp260","article-title":"Voluntary and mandatory surveillance for methicillin-resistant Stapylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England","volume":"64 Suppl 1","author":"Pearson","year":"2009","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003340","article-title":"Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization","author":"Loeb","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcf.2009.11.009","article-title":"Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres","volume":"9","author":"Doe","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0034|cit34","unstructured":"Methicillin-resistant Staphylococcus aureus (MRSA) 2008 Available at https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-12\/MRSA.pdf 2008"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009650.pub2","article-title":"Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","author":"Lo","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009650.pub3","article-title":"Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","author":"Lo","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD123456.pub4","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","author":"Lo","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009650.pub6-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009650.pub5","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","author":"Lo","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0039|cit39","unstructured":"Higgins JPT Lasserson T Thomas J Flemyng E Churchill R Methodological Expectations of Cochrane Intervention Reviews https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/mecir-manual"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD009650.pub6-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD009650.pub6-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thorax.55.11.946","article-title":"Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis","volume":"55","author":"Gee","year":"2000","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0043|cit43","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5.1 Cochrane, 2025 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD009650.pub6-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009650","article-title":"Interventions for the eradication of methicillin resistant Staphylococcus aureus in people with cystic fibrosis","author":"Lo","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thoraxjnl-2016-208949","article-title":"Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial","volume":"72","author":"Muhlebach","year":"2017","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0046|cit46","first-page":"275","article-title":"Occurrence of high-persister strains of MRSA in cystic fibrosis","volume":"54 Suppl 2","author":"Muhlebach","year":"2019","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0047|cit47","first-page":"2022","article-title":"Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-TER trial","volume":"8","author":"Cunningham","year":"2022","journal-title":"European Respiratory Journal Open Research"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0048|cit48","first-page":"327","article-title":"MRSA types in new onset infection \u2013 results from Star-TOO trial","volume":"50 Suppl 41","author":"Muhlebach","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1569-1993(15)30007-2","article-title":"Efficacy of a protocol for eradication of newly acquired MRSA: results of the STAR-TOO trial","volume":"14 Suppl 1","author":"Goss","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thoraxjnl-2016-208949","article-title":"Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial","volume":"72","author":"Muhlebach","year":"2017","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0051|cit51","unstructured":"Early methicillin-resistant Staphylococcus aureus (MRSA) therapy in cystic fibrosis (CF) (STAR-TOO) clinicaltrials.gov\/ct2\/show\/NCT01349192"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0052|cit52","first-page":"350","article-title":"Risk factors for methicillin-resistant staphylococcus aureus (MRSA) persistence in persons with cystic fibrosis (CF): analysis of the STAR-TOO cohort","volume":"52 Suppl 47","author":"Somayaji","year":"2017","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0053|cit53","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0054|cit54","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0055|cit55","unstructured":"Deeks JJ Higgins JPT Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0058|cit58","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0059|cit59","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0060|cit60","first-page":"149","article-title":"Emerging therapies in cystic fibrosis: Aerovanc for the treatment of chronic MRSA","volume":"50 Suppl 41","author":"Dasenbrook","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0061|cit61","unstructured":"Efficacy and safety study of AeroVanc for the treatment of persistent MRSA lung infection in cystic fibrosis patients clinicaltrials.gov\/ct2\/show\/NCT01746095"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0062|cit62","first-page":"298","article-title":"Pharmacokinetics of vancomycin in plasma and sputum following pulmonary administration in cystic fibrosis patients with persistent methicillin-resistant Staphylococcus aureus infection","volume":"51 Suppl 45","author":"Marich","year":"2016","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcf.2018.07.005","article-title":"Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis","volume":"18","author":"Dezube","year":"2019","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0064|cit64","first-page":"314","article-title":"Update on the persistent methicillin-resistant Staphylococcus aureus eradication protocol (PMEP) trial","volume":"50 Suppl 41","author":"Dezube","year":"2015","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl 47","key":"10.1002\/14651858.CD009650.pub6-BIB0065|cit65","first-page":"361","article-title":"Results of the persistent methicillin-resistant Staphylococcus aureus eradication protocol (PMEP) trial","volume":"52","author":"Jennings","year":"2017","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0066|cit66","first-page":"123","article-title":"Design of a clinical trial to eradicate persistent MRSA: the path from hypothesis to implementation","volume":"47 Suppl","author":"Dasenbrook","year":"2012","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1745-6215-15-223","article-title":"Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis - the PMEP trial: study protocol for a randomized controlled trial","volume":"15","author":"Jennings","year":"2014","journal-title":"Trials"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0068|cit68","unstructured":"Persistent methicillin resistant Staphylococcus aureus eradication protocol (PMEP) clinicaltrials.gov\/ct2\/show\/NCT01594827"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e0213497","DOI":"10.1371\/journal.pone.0213497","article-title":"Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study","volume":"14","author":"Dolce","year":"2019","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0070|cit70","first-page":"309","article-title":"Early antibiotic treatment for MRSA eradication in cystic fibrosis patients: a multicenter RCT","volume":"51 Suppl 45","author":"Neri","year":"2016","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0071|cit71","unstructured":"MRSA study www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2013-000219-25-IT"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0072|cit72","unstructured":"A study of AeroVanc for the treatment of MRSA infection in CF patients Staphylococcus aureus clinicaltrials.gov\/ct2\/show\/NCT03181932"},{"issue":"4","key":"10.1002\/14651858.CD009650.pub6-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1183\/23120541.00190-2022","article-title":"Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial","volume":"8","author":"Cunningham","year":"2022","journal-title":"ERJ Open Research"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0074|cit74","unstructured":"Staph aureus resistance-treat early and repeat (STAR-TER) (STAR-TER) clinicaltrials.gov\/study\/NCT03489629"},{"issue":"10","key":"10.1002\/14651858.CD009650.pub6-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0076|cit76","first-page":"S40","article-title":"Incidence and treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients: a cohort study","volume":"51 Suppl 42","author":"Bittencourt","year":"2016","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhin.2003.12.003","article-title":"Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection","volume":"56","author":"Garske","year":"2004","journal-title":"Journal of Hospital Infection"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.rmed.2015.01.013","article-title":"Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre","volume":"109","author":"Hall","year":"2015","journal-title":"Respiratory Medicine"},{"issue":"10","key":"10.1002\/14651858.CD009650.pub6-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/ppul.23519","article-title":"Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: a single center observational study","volume":"51","author":"Kappler","year":"2016","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD009650.pub6-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhin.2006.10.011","article-title":"Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol","volume":"65","author":"Macfarlane","year":"2007","journal-title":"Journal of Hospital Infection"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcf.2003.12.010","article-title":"Eradication of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis with linezolid","volume":"3","author":"Serisier","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"pii: 00064","DOI":"10.1183\/23120541.00064-2015","article-title":"MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis","volume":"2","author":"Valli\u00e8res","year":"2016","journal-title":"ERJ Open Research"},{"issue":"6","key":"10.1002\/14651858.CD009650.pub6-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jcf.2013.04.009","article-title":"Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients","volume":"12","author":"Vanderhelst","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2012.06.005","article-title":"A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF","volume":"12","author":"Dalb\u00f8ge","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"9","key":"10.1002\/14651858.CD009650.pub6-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/08035250600752466","article-title":"Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis","volume":"95","author":"Frederiksen","year":"2006","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0086|cit86","first-page":"246","article-title":"Effect of aerosolised rhDnase (Pulmozyme\u00ae) on pulmonary infections in CF: an open randomised study","volume":"Suppl 20","author":"Frederiksen","year":"2000","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0087|cit87","first-page":"335","article-title":"A clinically-embedded trial to evaluate the efficacy of interventions for pre-pseudomonal pathogens","volume":"48 Suppl 36","author":"Singh","year":"2013","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD009650.pub6-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4187\/respcare.04038","article-title":"Zinc supplementation for one year among children with cystic fibrosis does not decrease pulmonary infection","volume":"61","author":"Sharma","year":"2016","journal-title":"Respiratory Care"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0089|cit89","unstructured":"Khorasani EN Mansouri F Effect of zinc supplementation on respiratory infections in children with cystic fibrosis European Respiratory Society Annual Congress; 2009; Sept 12-16; Vienna, Austria 2009 722s"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0090|cit90","doi-asserted-by":"crossref","unstructured":"Flume P VanDevanter DR Cohen F Fleming R Elborn JS Safety profile of levofloxacin inhalation solution from 3 controlled cystic fibrosis trials Journal of Cystic Fibrosis 2015 14 Suppl 1 S87","DOI":"10.1016\/S1569-1993(15)30294-0"},{"issue":"11","key":"10.1002\/14651858.CD009650.pub6-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","article-title":"Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa","volume":"183","author":"Geller","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1569-1993(10)60087-2","article-title":"Effects of inhaled MP-376 (Aeroquin, levofloxacin inhalation solution) on lung function in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection","volume":"9 Suppl 1","author":"Flume","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD009650.pub6-BIB0093|cit93","first-page":"A2239","article-title":"Phase 2b study of inhaled MP-376 (Aeroquin, levofloxacin inhalation solution) in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection","volume":"181","author":"Conrad","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S1569-1993(11)60105-7","article-title":"Effects of inhaled MP-376 (Aeroquin\u2122 levofloxacin inhalation solution) on cystic fibrosis patients with both Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) lung infection","volume":"10 Suppl 1","author":"Flume","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"11","key":"10.1002\/14651858.CD009650.pub6-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","article-title":"Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa","volume":"183","author":"Geller","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0096|cit96","first-page":"301","article-title":"Effects of inhaled MP-376 (aeroquin, levofloxacin inhalation solution) on the need for other anti-pseudomonal antimicrobials in stable CF patients with chronic pseudomonas aeruginosa lung infection","volume":"45 Suppl 33","author":"Geller","year":"2010","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009650.pub6-BIB0097|cit97","first-page":"305","article-title":"An open label, randomised, two-way crossover scintigraphic study to investigate lung deposition of radiolabelled alginate oligosaccharide delivered as a dry powder and as a nebulised solution in cystic fibrosis patients","volume":"49 Suppl 38","author":"Hodges","year":"2014","journal-title":"Pediatric Pulmonology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:17:31Z","timestamp":1791893851000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009650.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":97,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009650.pub6","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}